Rt-pa with antithrombotic therapies in a case with capsular warning syndrome

14Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

We herein report a case of capsular warning syndrome (CWS) that was successfully treated with recombinant tissue plasminogen activator (rt-PA). A 70-year-old woman had repeated stereotyped transient ischemic attacks (TIAs) of right hemiparesis and dysarthria. After hospitalization, argatroban, aspirin, and cilostazol were started but were ineffective. Thirteen hours after the first episode of TIAs, severe symptoms occurred. Magnetic resonance imaging showed acute infarctions in the internal capsule to corona radiata, so we used rt-PA. Since then, the TIAs have not occurred, and the symptoms have considerably improved. This case suggests that rt-PA might be effective and safe for use in treating CWS.

Cite

CITATION STYLE

APA

Fuseya, Y., Kawamura, M., Matsuda, E., Takada, K., Watanabe, K., Fujitake, J., & Nakaya, Y. (2017). Rt-pa with antithrombotic therapies in a case with capsular warning syndrome. Internal Medicine, 56(4), 441–444. https://doi.org/10.2169/internalmedicine.56.7522

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free